KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Current Assets (2016 - 2026)

Idexx Laboratories has reported Current Assets over the past 17 years, most recently at $1.4 billion for Q4 2025.

  • For Q4 2025, Current Assets rose 1.0% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $1.4 billion, up 1.0%, while the annual FY2025 figure was $1.4 billion, 1.0% up from the prior year.
  • Current Assets for Q4 2025 was $1.4 billion at Idexx Laboratories, down from $1.5 billion in the prior quarter.
  • Over five years, Current Assets peaked at $1.5 billion in Q2 2024 and troughed at $938.0 million in Q3 2021.
  • A 5-year average of $1.2 billion and a median of $1.2 billion in 2023 define the central range for Current Assets.
  • Biggest five-year swings in Current Assets: surged 52.19% in 2021 and later decreased 12.27% in 2025.
  • Year by year, Current Assets stood at $955.7 million in 2021, then increased by 15.26% to $1.1 billion in 2022, then surged by 35.75% to $1.5 billion in 2023, then dropped by 6.38% to $1.4 billion in 2024, then rose by 1.0% to $1.4 billion in 2025.
  • Business Quant data shows Current Assets for IDXX at $1.4 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.4 billion in Q2 2025.